Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 1.3.2021 | EN | Official Journal of the European Union | C 72/21 |

---

Judgment of the General Court of 20 January 2021 — Stada Arzneimittel v EUIPO — Optima Naturals (OptiMar)

(Case T-261/19) [(1)](#ntr1-C_2021072EN.01002101-E0001)

(EU trade mark - Opposition proceedings - Application for the EU figurative mark OptiMar - Earlier national word mark Mar - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2021/C 72/30)

Language of the case: English

Parties

Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: J.-C. Plate and R. Kaase, lawyers)

Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Optima Naturals Srl (Gallarate, Italy) (represented by: S. Brustia and E. Montelione, lawyers)

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 31 January 2019 (Case R 1348/2018-1), relating to opposition proceedings between Stada Arzneimittel and Optima Naturals.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Stada Arzneimittel AG to pay the costs. |

---

---

[Top](#document1)